Nurse Practitioner, Gerontology · Soldotna, AK
NPI
1124683636
Since 2019
Specialty
Nurse Practitioner, Gerontology
Code 363LG0600X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
240 Hospital Pl
Soldotna, AK, 99669
Phone (907) 714-4502
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
602 services
Medicare patients, 2024
278
Average age 75
Drug cost, 2024
$3.0M
969 prescriptions
Company payments, 2025
$222
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dana L Oswald was code 99214 (office e&m - established), 501 times for 237 patients. In total Dana L Oswald billed 602 services in 4 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 501 | 237 | $77.36 | $39K |
| 99215 Office E&M - Established | Facility | 73 | 68 | $119.42 | $8,718 |
| 99213 Office E&M - Established | Facility | 27 | 22 | $50.67 | $1,368 |
By year: 2022 $47K for 603 services; 2023 $65K for 784 services; 2024 $49K for 602 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dana L Oswald prescribed most often to Medicare patients was Anastrozole, with 101 prescriptions and refills. In total Dana L Oswald wrote 969 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 101 | 253 | 30 | $2,797 |
| Ondansetron Odt Ondansetron | 98 | 100 | 56 | $1,158 |
| Prochlorperazine Maleate Generic | 79 | 79 | 53 | $777 |
| Acyclovir Generic | 51 | 69 | 16 | $425 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 49 | 52 | 31 | $616 |
| Xtandi Enzalutamide | 39 | 39 | Under 11 | $506K |
| Imatinib Mesylate Generic | 37 | 37 | Under 11 | $33K |
| Hydroxyurea Generic | 29 | 36 | Under 11 | $602 |
| Imbruvica Ibrutinib | 29 | 29 | Under 11 | $307K |
| Dexamethasone Generic | 27 | 37 | 13 | $526 |
| Calquence Acalabrutinib Maleate | 23 | 23 | Under 11 | $266K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 33 | Under 11 | $52.09 |
| Alunbrig Brigatinib | 21 | 21 | Under 11 | $409K |
| Lenalidomide Generic | 19 | 19 | Under 11 | $214K |
| Revlimid Lenalidomide | 18 | 18 | Under 11 | $286K |
Brand drugs: 219 claims; generic drugs: 750 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dana L Oswald $222 ($222 in general payments such as food, travel and fees) from 2 companies. The largest payer was EMD Serono, Inc. with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.